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The effectofseveral chelating agents (diethyldithiocarbamic acid, DDC; nitrilotriacetic
acid, NTA; 2,3-dimercaptopropanol, BAL; d,-penicillamine, PEN; 2,3-dimercaptosuccinic
acid, DMSA; ethylenediaminetetraacetic acid, EDTA; and diethylenetriaminepentaacetic
acid, DTPA) on the toxicity, distribution and excretion ofcadmium (Cd) was determined
in mice. When chelators were administered immediately after Cd, significant increases in
survival were noted after treatment with DMSA, EDTA, and DTPA. DTPA, followed by
EDTA and then DMSA, were consistently the most effective in decreasing the tissue
concentrations ofCdandincreasingtheexcretion ofCd. NTA,BAL,DDC and PEN had no
beneficial effects.
The effects ofincreasing the time interval between Cd administration and initiation of
chelation therapy was determined by using a single administration ofDTPA, EDTA, and
DMSA. Mice treated immediately after Cd administration excreted approximately 50% of
the administered dose of Cd compared to 0.2% in controls. Ireatment with chelator at
later times significantly increased Cd excretion butthe magnitude ofthe effect was much
less than that seen in mice treated immediately after Cd.
To determine the role of MT in the acute decrease in chelator efficacy following Cd
poisoning, rats were injected IV with Cd followed by DTPA at various times after Cd.
Although DTPA reduced Cd content in the various organs when given immediately after
Cd, the chelator was ineffective at all later times. Increases in hepatic and renal metal-
lothionein (MT) did not occur until 2 hr after Cd, and did not coincide with the earlier
drop in chelator efficacy. Blockade ofMT synthesis by actinomycin D failed to eliminate
this decreased DTPA effectiveness. Therefore, it appears that MT does not play an
important role in the acute decrease in efficacy ofchelation therapy for Cd poisoning.
The effect ofrepeated daily administration ofchelators on the distribution and excre-
tion ofCd was studied by administering chelators daily for 5 days starting 48 hr after Cd.
DTPA, EDTA, DMSA and BAL significantly increased the urinary elimination of Cd.
Thus, mobilization of Cd into urine occurs with repeated chelation therapy, which may
decrease tissue concentrations ofCd and reduce the toxicity ofthe metal.
The LD50 values for the various chelators stud-
ied are shown in Table 1. Marked differences in
the toxicity of the chelators was observed: NTA,
BAL and PEN were very toxic, while DDC,
DMSA and DTPA were moderately toxic, and
EDTA was only slightly toxic. The dose of chela-
tor chosen for the subsequent studies was approx-
imately one-fourth ofthe respective LD.% value.
The effectofthevariouschelating agents onthe
lethality of Cd is shown in Figure 1. Mice which
received saline after Cd are shown as control.
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Previous work in our laboratory has shown that
the IVLD50for Cdis approximately 3.5 mgCd/kg.
In control mice receiving 4 mg Cd/kg, 40% sur-
vival was seen which is consistent with the re-
ported LD50. At doses ofCd greater than 4 mgCd!
kg no survival was seen in control mice. No
protective effect was observed with administra-
tion ofPEN, BAL or NTA. Slight protection was
seen with DDC at 4 and 6 mg Cd/kg (70 and 60%
survival, respectively), butnoprotectionwasseen
with DDC at the two higher doses of Cd. An
increase in survival was also noted with DMSA,
ranging from 70 to 50% at all doses ofCd. Treat-
ment with EDTA provided even greater protec-
tion, approximately 80% survived at all doses ofTable 1. LD50 values ofchelators.a
LD50 Dose
used,
Chelator nmole/kg g/kg g/kgb
Sodium diethyldithiocarbamic acid (DDC) 8.35 1.40 0.35
Disodium nitrilotriacetic acid (NTA) 1.70 0.40 0.10
2,3-Dimercaptopropanol (BAL) 0.85 0.11 0.027
Pencillamine (PEN) 2.53 0.38 0.095
2,3-Dimercaptosuccinic acid (DMSA) 16.2 2.95 0.74
Calcium disodium ethylenediaminetetraacetic acid (EDTA) 16.4 6.11 1.50
Calcium trisodium diethylenetriaminepentaacetic acid (DTPA) 6.94 3.60 0.90
aChelators were administered IP to groups of10 mice per dose. Survival was recorded at the end of 14 days.
bRefers to the dosage ofchelators used in the subsequent comparisons ofthe chelators.
Cd tested. The most dramatic protection was ob-
served with DTPA which completely protected
mice up to 8 mg Cd/kg (i.e., greater than two
times the IV LD50 for Cd).
The effectofthe chelators onthe excretion ofCd
into urine and feces is shown in Figure 2. The
amount ofCd excreted (jig Cd/kg body weight) in
24 hr is shown for all treatments. Significant
increases in urinary excretion of Cd (top panel,
Fig. 2) were caused by PEN, DMSA, EDTA and
DTPA. The effects of both EDTA and DTPA are
especially noteworthy as they caused excretion of
50 and 60% ofthe administered Cd, respectively.
No increase in urinary excretion of Cd was seen
after DDC, NTA or BAL. The excretion ofCd into
feces (bottom panel, Fig. 2) shows that this is the
major route of elimination for Cd in control ani-
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FIGURE 1. Effect ofthe indicated chelators on the lethality of
Cd. Cd was administered intravenously, immediately fol-
lowed by one ofthe chelators or saline (control). Chelators
were given at a dose approximately equal to one-fourth of
their respective LD50 (shown in Table 1). Each point repre-
sents the percentage survival of 10 animals. From Canti-
lena and Klaassen (1).
mals. The agents which caused an increase in
urinary excretion of Cd caused a corresponding
decrease in fecal elimination of the metal. No
significant effect on fecal elimination of Cd was
observed after DDC, NTA, BAL and PEN.
FIGURE 2. Effect ofthe indicated chelators on the amount of
Cd excreted in 24 hr(gg Cd/kgbody weight). The chelators
were given IP immediately after Cd (1 mg Cd/kg) at a dose
approximately equal to one-fourth oftheir respective LD50
(shown in Table 1). Bars indicate SE, n = 6. An asterisk
indicates significantly different from control. From Canti-
lena and Klaassen (1).
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FIGURE 3. Cd concentrations in the indicated tissues of mice 24 hr after treatment with
various chelators. Chelators were given IP immediately after Cd at a dose approximately
equal to one-fourth oftheir respective LD50 (shown in Table 1). Bars indicate SE, n = 6.
An asterisk indicates significantly different from control. From Cantilena and Klaassen
(1).
The effect ofthe chelators on tissue distribution
ofCd is shown in Figure 3. Note that the scale of
the ordinate changes in the bottom two panels of
the figure. The concentration of Cd (rig Cd/g tis-
sue) is shown for each treatment group. The up-
per left quadrant shows the concentration of Cd
found in liver, the main storage site of adminis-
tered Cd in the body. Treatment with PEN,
DMSA, EDTA and DTPA significantly reduced
the amount ofCd found in liver with DTPA being
the most effective.
The upper right quadrant ofFigure 3 shows the
results from kidney, the main target organ of
chronic Cd exposure. The agents which decreased
tissue Cd levels in kidney were EDTA and DTPA.
Penicillamine (PEN) caused a threefold increase
in kidney Cd concentration. A similar increase,
though not ofthe same magnitude, was seen after
treatment with BAL. No significant change in Cd
concentration in kidney was seen in mice treated
with DDC, NTA, or DMSA.
The results from testes, another target organ of
Cd toxicity, are shown in the lower left quadrant
of Figure 3. Similar to their effects on kidney,
EDTA and DTPA significantly lowered the
amount of Cd in testes. A significant decrease in
testicular Cd concentration was also observed af-
ter DMSA. No significant changes in testicular
Cd concentrations were seen with NTA, BAL or
PEN. Similar to what was observed with PEN
and BAL in the kidney, DDC significantly in-
creased the concentration ofCd in testes.
The effect of treatment with the chelators on
brain Cd concentrations is shown in the lower
right quadrant of Figure 3. The brain normally
receives very little Cd relative to other body tis-
sues. Treatment with DMSA and DTPA caused a
significant decrease in tissue Cd concentrations.
Similarto its effect in testes, DDC caused a signifi-
cant increase in brain Cd, almost a 20-fold in-
crease compared to controls.
Histopathological examination ofrenal tissues
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from animals that received Cd only (1 mg Cd/kg),
24 hr before sacrifice, did not reveal any signifi-
cant pathological lesions. Similarly, renal tissue
from mice given Cd and DDC, or Cd and NTA did
not show any evidence of damage. Minor focal
necrosis with swelling was noted in the convo-
lutedproximal tubules of2/6 and3/6oftheEDTA-
and DTPA-treated animals, respectively. The fo-
cal necrosis inthe EDTA group involved less than
30% of the nephrons with less than 50% of the
length ofthe involved segmentsbeingnecrotic. In
the DTPA group, less than 50% of the nephrons
were involved. In two of six mice receiving BAL
after Cd, rare segmental necrosis ofthe proximal
tubule was found. Less than 10% ofthe nephrons
were involved. Treatment with DMSA after Cd
resulted in varying degrees of necrosis in the
convoluted proximal tubule ofall six mice exam-
ined. The degree of damage varied from minor
focal necrosis to extensive uniform necrosis. The
most severe lesions were observed in Cd-poisoned
mice treated with PEN. Treatment with PEN
resulted in extensive necrosis ofthe distal portion
of the convoluted proximal tubule (pars recta)
with swelling and fragmentation of cells and
some loss of nuclei. Most, but not all, of the
nephrons were involved. The distal nephron and
glomeruli were uninvolved, as were most of the
initial segments ofthe convoluted tubules. Along
the basement membrane, occasional residual or
flattened nuclei were found. There was no evi-
dence of mitosis or any other component of re-
generation noted.
The effect of increasing the time interval be-
tween Cd administration and initiation ofchela-
tion therapy was determined using a single ad-
ministration ofDTPA, EDTA orDMSA. The effect
ofthe chelating agents on daily urinary elimina-
tion ofCd for each day after administration ofCd
is shown in the five panels (top to bottom) of
Figure 4. The scale of the ordinate (jg Cd ex-
creted/kg body weight) is not the same in all
panels. The excretion of Cd from mice receiving
either saline (control) or one ofthethree chelators
at various times after Cd administration (0, 2, 12,
36 or 72 hr) is shown from left to right in each
panel. Urinary excretion data for groups which
had not yet received chelator treatment are omit-
ted for clarity.
During the first 24 hr after Cd administration
(day 1, Fig. 4), the first three groups (0, 2, and 12
hr) received chelation treatment. Saline-treated
controls in these three groups excreted approxi-
mately 1 jg Cd/kg during this period. Treatment
with DTPA significantly increased urinary excre-
tion of Cd in all three groups during day 1. The
DTPA-treated mice excreted 500, 50 and 2.5 jg
Cd/kg when treated at 0, 2 and 12 hr, respec-
tively. TreatmentwitheitherEDTAorDMSAat0
or 2 hr after Cd also markedly increased urinary
elimination ofCd.
Excretion of Cd into urine during day 2 is
shown in the second panel from the top ofFigure
4. Mice which received either DTPA or DMSA
immediately after Cd (0 hr) had an increased
urinary elimination ofCd on the second day after
administration. Mice which received chelation
therapy 2 hr after Cd did not excrete more Cd
thantheirrespective control. The animalstreated
36 hr after Cd received their respective chelator
12 hr into the day 2 collection period. Treatment
with DTPA, but not with EDTA or DMSA, signifi-
cantly increased the urinary elimination ofCd at
this time.
The third panel from the top ofFigure 4 shows
the urinary elimination of Cd during the third
day after Cd administration. No group received
treatment on the third day. Mice which received
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FIGURE 4. Effect of DTPA (DT), EDTA (E), and DMSA (DM)
administered at the indicated times after Cd (O to 72 hr) on
the urinaryelimination ofthe metal. The dailyexcretion of
Cd oftreated groups is shown for 5 consecutive days after
Cd (days 1-5). Bars indicate SE, n = 5 to 8. An asterisk
indicates significantly different from control (p < 0.05).
From Cantilena and Klaassen (2).
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FIGURE 5. Effect ofthe indicated chelators on the fecal elimi-
nation ofCd. Chelating agents were administered immedi-
ately after Cd. Fecal elimination during the first 2 days
post-Cd is shown. Bars indicate SE, n = 5 to 8. An asterisk
indicates significantly different from control (p < 0.05).
From Cantilena and Klaassen (2).
either DTPA or DMSA 0 hr after Cd still excreted
more Cd than the control group. However, during
this period the mice were excreting only 1 to 2.5
jg Cd/kg compared to the 500 jg Cd/kg they
eliminated during day 1.
The urinary elimination of Cd during day 4 is
shown in the fourth panel from the top ofFigure
4. Significant increases in the amount of Cd
eliminated by mice given DTPA or DMSA imme-
diately after Cd (0 hr) were observed. During day
4, the 72-hr groupreceivedchelationtherapy. The
mice treated at this time with DTPA or EDTA
excretedmore Cd intotheurine thantheir respec-
tive controls.
The bottom panel ofFigure 4 showsthe urinary
elimination ofCdduringday 5. After 5 days, mice
which received DTPA or DMSA immediately af-
ter Cd (0 hr) continued to excrete more Cd than
controls. Similarly, mice which received DTPA 72
hr after Cd excreted more Cd than controls.
The effect ofadministration ofDTPA, EDTA, or
DMSA immediately after Cd on its elimination
into feces is shown in Figure 5. Treatment with
DTPA, EDTA, or DMSA decreasedthe fecal elimi-
nation ofCd by approximately 50% during day 1
(top panel) and approximately 50 to 70% during
day 2 (bottom panel). The excretion of Cd into
feces by control mice diminished with time from
80 jg Cd/kg during day 1 (Fig. 5) to 2 gg Cd/kg
duringday 5 (data not shown). The excretion data
ofthe 0-hr group for day 1 (top panel) and day 2
(bottom panel) are the only fecal excretion data
shownbecause all other groups (2, 12, 36 or 72 hr)
and days (3 to 5) showed no statistically signifi-
cant effects.
The effect of chelation treatment at various
times after Cd administration on the concentra-
tion ofCd in kidney, the main target organ ofCd
toxicity, is shown in Figure 6. Administration of
DTPA, EDTA, or DMSA immediately after Cd (0
hr) resulted in a significant decrease in the con-
centration of Cd in kidneys 5 days later. DTPA,
EDTA and DMSA produced 70, 60 and 30% de-
creases in renal Cd content, respectively. Chela-
tor treatment at later times did not significantly
affect the concentration ofCd in kidneys.
The time course for effectiveness of the chela-
tors in removing Cd from liver, the main storage
site for Cd in the body, is shown in Figure 7.
Treatment with DTPA, EDTA or DMSA at 0 hr
ohr
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FIGURE 6. Effect ofadministration ofthe indicated chelators
at various times (O to 72 hr) after Cd exposure on the
concentration ofCd in kidney. Bars indicate SE, n = 5 to 8.
An asterisk indicates significantly different from control.
From Cantilena and Klaassen (2).
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FIGURE 7. Effect of administration ofthe indicated chelators
at various times (0 to 72 hr) after Cd exposure on the
concentration ofCd in liver. Bars indicate SE, n = 5 to 8.
An asterisk indicates significantly different from control.
From Cantilena and Klaassen (2).
resulted in a significant decrease (75 to 80%) in
concentration of Cd in liver; administration of
chelators at later times had no significant effect.
Similar results were obtained in testes (Fig. 8)
and in brain (Fig. 9), inthat administration ofthe
chelators only immediately after Cd (0 hr) re-
sulted in a significant decrease in concentration
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FIGURE 9. Effect of administration ofthe indicated chelators
at various times (O to 72 hr) after Cd exposure on the
concentration ofCd in brain. Bars indicate SE, n = 5 to 8.
An asterisk indicates significantly different from control.
From Cantilena and Klaassen (2).
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FIGURE 8. Effect ofadministration ofthe indicated chelators
at various times (O to 72 hr) after Cd exposure on the
concentration ofCd in testes. Bars indicate SE, n = 5 to 8.
An asterisk indicates significantly different from control.
From Cantilena and Klaassen (2).
ofCd inthese tissues. Thistrendwas observed for
the other tissues examined (data now shown) in
that statistically significant decreases in tissue
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ous short intervals (0, 15,30,60 and 120 min) on the organ
retention of Cd 24 hr following IV administration (1 mg
Cd/kg; time 0) in young adult rats. Values represent ±
SE for six rats. The broken line represents x + SE for
controls (no DTPA). An asterisk indicates significantly
different from control (p < 0.05). From Waalkes et al. (3).
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FIGURE 11. Time course of MT concentration in liver and
kidney following IV administration of Cd (1 mg Cd/kg).
Values represent + SE for six rats. An asterisk indicates
significantly different (p < 0.05) from basal concentrations
(time 0). From Waalkes et al. (3).
Cd concentrations were only noted in mice that
received chelation therapy immediately after Cd.
Tb determine the time of onset for decreased
effectiveness of chelators after Cd exposure, rats
were injected with DTPA (90 mg/kg, IP) at vari-
ous times (0, 15, 30, 60 and 120 min) after Cd
exposure (1 mg/kg, IV; time 0), and 24 hr later the
amount of Cd in various tissues was quantified
(Fig. 10). DTPA markedly lowered the amount of
Cd remaining in liver, kidney, lung, stomach,
heart, and brain at 24 hr when given immedi-
ately after Cd. However, if DTPA was delayed as
little as 15 min, the chelator was ineffective. The
amount ofCd in the various tissues ofrats receiv-
ing DTPA at 15, 30, 60 or 120 min following Cd
was not different from control (no chelator). The
retention ofCd in the spleen (data not shown) was
not affected by DTPA therapy.
The concentration ofMT in liver and kidney at
varioustimesfollowing Cd (1 mg Cd/kg, IV) treat-
ment is shown in Figure 11. There was no signifi-
cant increase in MT concentration in either organ
until 2 hr after Cd injection. Between 2 and 24 hr
there was a significant increase in MT in both
liver and kidney. MT levels reached a plateau in
both organs between 4 and 12 hr after Cd injec-
tion which was 6.4 and 2.5 times higher than
basal levels for liver and kidney, respectively.
The effect ofactinomycin D pretreatment (1.25
mg/kg, IP) on the induction ofhepatic and renal
MT 4 hr following Cd (when MT levels are ap-
proximately maximal) is shown in Figure 12. In
animals pretreated with vehicle 1 hr prior to Cd,
there was a marked increase in both hepatic and
renal MT concentrations. However, rats receiving
actinomycin D had no significant increase in MT
over controls in either organ.
Despite the block ofMT synthesis with actino-
mycin D, the pronounced decrease in DTPA effi-
cacy was still evident at 15 min (Fig. 13). The
amount ofCd in various tissues in the actinomy-
cinD-pretreated rats givenDTPA 15 min afterCd
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FIGURE 12. Effect of actinomycin D (ACT) pretreatment on
the concentration ofMT in liver and kidney 4 hr following
Cd. Values represent + SE offour rats. The ACT + Cd
group received 1.25 mg actinomycin D/kg 1 hr prior to Cd
(1 mg Cd/kg, IV); the Cd group received actinomycin D
vehicle (10 mL/kg) 1 hr prior to Cd; and controls received
actinomycin D vehicle (10 mL/kg) 1 hr prior to saline (10
mL/kg). An asterisk indicates significantly different from
control (p < 0.05). From Waalkes et al. (3).
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FIGURE 13. Effect ofactinomycin D (ACT) pretreatment (1.25 mg/kg, IP) 1 hr prior to Cd (1
mg/kg, IV; time 0) on the efficacy ofDTPA (90 mg/kg) given at various times following Cd
as assessed by organ retention ofthe metal 24 hrlater. All groups received actinomycin D
and Cd treatments followed by DTPA at varioustimes (0, 15 min or 4 hr) or saline. Values
representx + SE offourrats. An asterisk indicates significantly different (p < 0.05) from
the group receiving no DTPA. From Waalkes et al. (3).
was not significantly different from that in rats
that did not receive the chelator.
The efficacy of DTPA was also determined in
newborn rats (5-day-old) following Cd injection (1
mg Cd/kg, IV). Hepatic MT concentration in 5-
day-old rats without any pretreatment was 1260
+ 45 jig MT/g wet weight (x + SE), which is
approximately 36 times the basal levels in young
adult rat liver (35.4 + 7.5). Despite these high
levels ofhepatic MT in newborn rats, DTPA was
still effective if given immediately following Cd
(Fig. 14). However, when DTPA administration
was delayed to 2 hr after Cd injection, it became
ineffective in both the newborn and adult rats.
The effect of repeated daily administration of
chelators on the distribution and excretion ofCd
wasstudiedbyadministering chelatorsdailyfor 5
days starting 48 hr after Cd. Daily Cd excretion
(jig/kg body weight) by mice that received one of
the various chelators or saline from day 3 today 7
(post-Cd administration) is shown in Figure 15.
During the first day oftreatment (day 3) signifi-
cant increases in urinary elimination ofCd were
found in mice treated with DTPA, EDTA, DMSA,
andBAL. DTPAproduced thegreatestincrease in
urinary elimination (approximately 100-fold). Al-
though this amount represents only 0.2% of the
total Cd dose, results obtained during successive
days (days 4 to 7) indicate DTPA, EDTA, DMSA
and BAL significantly increased the urinary ex-
cretion ofCd, with the exception ofDMSA on day
7 which was not significantly different from con-
trols. No significant effects on urinary elimina-
tion of Cd were observed in mice treated with
DDC, NTA, or PEN.
The amount of Cd eliminated into urine as a
result of treatment with DTPA was remarkably
constant on successive days. Approximately 2 jg
Cd/kg was eliminated daily during DTPA treat-
ment. In contrast, the urinary elimination of Cd
in mice treated with BALprogressively increased
during the course oftreatment.
The effect of repeated daily administration of
chelators on the fecal elimination of Cd was also
determined. Fecal excretion, the major route of
elimination of Cd, decreased with time after ad-
ministration ofCd in control animals. The excre-
tion of Cd into feces of control mice during the
first and second days was 96.4 + 11.7 and 40.5 ±
3.6 jg Cd/kg, respectively. Only DDC signifi-
cantly increased the fecal elimination of Cd (Ta-
ble 2), ranging from a 2-fold (day 3) to a 10-fold
increase (day 7). All other chelators had no effect
on fecal Cd elimination (data not shown).
Histopathological examination indicated that
no significant pathological lesionswerepresent in
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FIGURE 14. Effect ofDTPA treatment (90 mg/kg, IP) at vari-
ous intervals (0 and 2hr) followingIV Cdadministration (1
mg/kg; time 0) on the organ retention of the metal 24 hr
later in young adult (40-day-old) and newborn (5-day-old)
rats. Values represent * + SE ofsix ratswhich,d-in the case
ofthenewbors, were derivedfromthreeormorelitters. An
asteriskindicatessignificantly different(p < 0.05)fromthe
appropriate control (no DTPA). From Waalkes et al. (3).
renal tissue ofany ofthe treatment groups.
In summary, chelation therapy of Cd intoxica-
tion is extremely effective when administered im-
mediately after Cd exposure. However, the effec-
tiveness ofchelation therapy decreases markedly
with time after exposure. This rapid decrease in
effectiveness occurs much quicker than the in-
crease in metallothionein after Cd exposure. The
decreased effectiveness ofchelators with time af-
ter Cd exposure appears to be due to the intracel-
lular distribution ofCd and the extracellular dis-
tribution of the chelators. While chelators are
much less effective when not administered imme-
diately after Cd exposure, tepresent study dem-
Table 2. Effect ofDDC on the fecal elimination ofCd.a
Cd excretion, p.g/kg body weight
Day Control DDC
3 8.77 ± 0.27 20.3 ± 1.27*
4 3.30 ± 0.30 22.7 ± 2.80*
5 2.01 ± 0.26 17.3 ± 1.12*
6 1.28 ± 0.21 14.5 ± 1.43*
7 1.38 ± 0.20 15.8 + 0.61*
aDaily administration of DDC (0.35 g/kg IP) was initiated
48 hr after Cd (1 mg Cd/kg, IV) and continued for 5 days. Cd
excretion is shown for each 24-hr period.
*Significantly different from control (p < 0.05).
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FIGURE 15. Effect ofrepeated daily administration ofvarious
chelatingagents onthedailyurinaryeliminationofCd(pg
Cd excreted/kg body weight). The indicated chelating
agents or saline (control) was administered for 5 days
beginning48hrafterCdadministration(days 3 to 7). Bars
indicate SE, n = 5. An asterisk indicates significantly
different from control. From Cantilena and Klaassen (4).
onstrates that repeated administration of chela-
tors does enhancetheurinary excretion ofCd and
provide hope that long-term therapy may de-
creasebodyburden andtoxicity ofCd.
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